Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer

被引:11
|
作者
Sandor, V
机构
来源
LANCET | 1997年 / 350卷 / 9087期
关键词
D O I
10.1016/S0140-6736(05)62486-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1325 / 1326
页数:2
相关论文
共 50 条
  • [1] Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer - Reply
    Levi, F
    Metzger, G
    Zidani, R
    Misset, JL
    [J]. LANCET, 1997, 350 (9087): : 1326 - 1326
  • [2] An alternating regimen of irinotecan/5-fluorouracil/folinic acid and oxaliplatin/5-fluorouracil/folinic acid in metastatic colorectal cancer: A phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Pasinetti, N
    Marini, G
    [J]. ONCOLOGY, 2005, 69 (04) : 283 - 289
  • [3] Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
    Levi, F
    Zidani, R
    Misset, JL
    [J]. LANCET, 1997, 350 (9079): : 681 - 686
  • [4] Oxaliplatin combined to 5-fluorouracil and folinic acid: an effective therapy in patients with advanced colorectal cancer
    Gerard, B
    Bleiberg, H
    Van Daele, D
    Gil, T
    Hendlisz, A
    Di Leo, A
    Fernez, B
    Brienza, S
    [J]. ANTI-CANCER DRUGS, 1998, 9 (04) : 301 - 305
  • [5] 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX) in very old patients with metastatic colorectal cancer.
    Figer, A
    Perez, N
    Carola, E
    Andre, T
    Chirivella, I
    Lledo, G
    Flesch, M
    Rivera, F
    Colin, P
    De Gramont, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 262S - 262S
  • [6] 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX) in poor prognosis patients with metastatic colorectal cancer.
    Tournigand, C
    Andre, T
    Chirivella, I
    Figer, A
    Lledo, G
    Flesch, M
    Lorenzo, JRM
    Achille, E
    Landi, B
    Hebbar, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 261S - 261S
  • [7] Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial
    Focan, C
    Kreutz, F
    Focan-Henrard, D
    Moeneclaey, N
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (03) : 341 - 347
  • [8] Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
    Garufi, C
    Brienza, S
    Pugliese, P
    Aschelter, AM
    Bensmaine, MA
    Bertheault-Cvitkovic, F
    Nisticò, C
    Giunta, S
    Caterino, M
    Giannarelli, D
    Cosimelli, M
    Lévi, F
    Terzoli, E
    [J]. ANTI-CANCER DRUGS, 2000, 11 (06) : 495 - 501
  • [9] Cardiotoxicity in 5-fluorouracil folinic acid treatment for metastatic colorectal cancer
    Käfer, G
    Achtnich, M
    Willer, A
    Weiss, A
    Queisser, W
    [J]. ONKOLOGIE, 1998, 21 (04): : 324 - 327
  • [10] HYDROXYUREA POTENTIATES FOLINIC ACID AND 5-FLUOROURACIL IN COLORECTAL-CANCER
    DEGRAMONT, A
    BENNAMOUN, M
    LOUVET, C
    VARETTE, C
    DEMUYNCK, B
    BEERBLOCK, K
    CADY, J
    GRANGE, JD
    LAGADEC, B
    MAISANI, JE
    DELFAU, S
    LOISEAU, JP
    SEROKA, J
    KRULIK, M
    [J]. REVUE DE MEDECINE INTERNE, 1992, 13 : S323 - S323